Metformin
Biguanide oral anti-diabetic. Used in bodybuilding to manage insulin sensitivity, especially alongside GH and MK-677. Also studied for longevity benefits.
Overview
Biguanide oral anti-diabetic. Used in bodybuilding to manage insulin sensitivity, especially alongside GH and MK-677. Also studied for longevity benefits.
Lowers fasting glucose and HbA1c, improves insulin sensitivity, can mildly lower LDL and triglycerides, may reduce B12 levels with long-term use, does not affect liver enzymes (may actually improve them), does not affect hormones
Compound Guide
Structure: Biguanide that reduces hepatic glucose production, increases insulin sensitivity, and delays intestinal glucose absorption. Does not stimulate insulin secretion (no hypoglycaemia risk as monotherapy).
Dosage:
- Insulin sensitiser (with GH/MK-677): 500mg 1-2x/day
- Standard: 500-1000mg 2x/day with meals
- Maximum: 2000-2500mg/day (split doses)
Administration:
- Oral tablet, always take with food (reduces GI side effects)
- Extended-release (XR) formulation significantly reduces GI sides — preferred
- Titrate up: start 500mg/day with dinner for 1-2 weeks, then increase
Key Notes:
- Primary bodybuilding use: counteract insulin resistance caused by GH, MK-677, or insulin use
- GI side effects (bloating, diarrhoea, nausea) are common initially — subside in 2-4 weeks
- Extended-release (XR) formulation is much better tolerated — ask for Metformin XR specifically
- Depletes Vitamin B12 with long-term use — supplement B12 and monitor levels annually
- Does NOT cause hypoglycaemia when used alone (unlike insulin or sulfonylureas)
- Some evidence of anti-aging / longevity benefits (AMPK activation, mTOR modulation)
- Concern: may mildly blunt muscle protein synthesis (mTOR inhibition) — debated
- Take at a different time than post-workout meals if concerned about mTOR blunting
- Monitor: fasting glucose, HbA1c, fasting insulin, Vitamin B12, liver enzymes, kidney function (eGFR)
Usage History
Frequently Asked Questions
Related Articles
On-Cycle Support Protocol: Every Supplement Mapped to Your Bloodwork
Evidence-based on-cycle support protocol with every supplement mapped to the blood markers it protects. Dosing, timing, and protocols by cycle type.
MK-677 & Insulin Resistance: Full HOMA-IR and Glucose Data (2026)
MK-677 raises fasting glucose to 6.8 mmol/L within 4 weeks and HbA1c by 0.2% at 12 months. Complete HOMA-IR data from human studies, when the numbers cross into pre-diabetes, and 5 evidence-based fixes.
Quick Reference
Category
Ancillary
Half-Life
5-6 hours (IR) / 8-12 hours (XR)
Detection Time
N/A